Inocule Genomics & CRISPR is envisioned as the Group’s future platform for genetic medicine, gene editing and genomic technologies. Development would begin through research collaborations, investments, licensing and specialist scientific teams.
RESEARCH PLATFORM. The platform is intended to develop through research, partnerships and specialist expertise before progressing selectively toward proprietary intellectual property, products or businesses.
Long-term area of interest within the platform.
Long-term area of interest within the platform.
Long-term area of interest within the platform.
Long-term area of interest within the platform.
Long-term area of interest within the platform.
Long-term area of interest within the platform.
The work begins with understanding the science and identifying practical opportunities. As evidence, capabilities and partnerships develop, selected programs can move toward deeper development and commercialization.
Inocule’s companies and research areas are designed to reinforce one another across biology, engineering, materials science, computation and manufacturing.